{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:28:41Z","timestamp":1774960121789,"version":"3.50.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.autrev.2014.05.004","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T05:16:45Z","timestamp":1399699005000},"page":"901-908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder"],"prefix":"10.1016","volume":"13","author":[{"given":"Silvia","family":"D'Ippolito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Veglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.05.004_bb0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2014.05.004_bb0010","doi-asserted-by":"crossref","first-page":"A299","DOI":"10.1016\/j.autrev.2009.11.013","article-title":"The geoepidemiology of the antiphospholipid antibody syndrome","volume":"9","author":"Biggioggero","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2014.01.006","article-title":"Diagnosis and classification of the antiphospholipid syndrome","volume":"48\u201349","author":"G\u00f3mez-Puerta","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.004_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International classification consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Myakis","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.autrev.2014.03.002","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome","volume":"13","author":"Cervera","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/CRIAI:25:1:61","article-title":"Unusual manifestations of the antiphospholipid syndrome","volume":"25","author":"Asherson","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/0961203312438116","article-title":"Obstetric and vascular APS: same autoantibodies but different diseases?","volume":"21","author":"Meroni","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.autrev.2011.10.006","article-title":"Obstetric antiphospholipid syndrome","volume":"11","author":"Galarza-Maldonado","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms","volume":"34","author":"Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncprheum0740","article-title":"Mechanisms of disease: antiphospholipid antibodies \u2014 from clinical association to pathologic mechanism","volume":"4","author":"de Laat","year":"2004","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2006-04-001206","article-title":"Current concepts on the pathogenesis of the antiphospholipid syndrome","volume":"109","author":"Giannakopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0060","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2011-09-381913","article-title":"Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study","volume":"119","author":"Gris","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12016-012-8316-0","article-title":"Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease","volume":"43","author":"Mart\u00ednez-Zamora","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0070","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0075","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-010-0144-8","article-title":"Autoantibodies directed against domain I of beta2-glycoportein I","volume":"13","author":"de Laat","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2014.05.004_bb0080","doi-asserted-by":"crossref","first-page":"379-4","DOI":"10.1177\/0961203310361352","article-title":"Pathophysiology of beta 2-glycoprotein I in antiphospholipid syndrome","volume":"19","author":"Matsuura","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/humupd\/dms020","article-title":"Anticardiolipin antibodies and recurrent pregnancy loss: a century of equivocal evidence","volume":"18","author":"Clark","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.autrev.2014.05.004_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms","volume":"34","author":"Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.autrev.2013.08.007","article-title":"Autoantibody profiling of patients with antiphospholipid syndrome using an automated multiplexed immunoassay system","volume":"13","author":"Tozzoli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1538-7836.2010.03857.x","article-title":"Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome","volume":"8","author":"de Moerloose","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.33349","article-title":"International consensus guidelines on anticardiolipin and anti-\u03b22-glycoprotein I testing","volume":"64","author":"Lakos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.004_bb0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.02.016","article-title":"Antiphospholipid antibody profiling: time for a new technical approach?","volume":"11","author":"Roggenbuck","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2014.05.004_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2013.11.004","article-title":"Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis","volume":"13","author":"Reynaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2012.05.006","article-title":"Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome","volume":"12","author":"Mahler","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0961203312443298","article-title":"Definition and significance of high positivity aCL ELISA","volume":"21","author":"Wahl","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0130","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acr.20098","article-title":"Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome","volume":"62","author":"Ruffatti","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2014.05.004_bb0140","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.autrev.2012.11.008","article-title":"Correct laboratory approach to APS diagnosis and monitoring","volume":"12","author":"Pengo","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0961203309347794","article-title":"Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome","volume":"19","author":"Bramham","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12016-009-8146-x","article-title":"Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome","volume":"38","author":"Blank","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0155","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0031-1293206","article-title":"Obstetric antiphospholipid syndrome: an update on pathophysiology and management","volume":"29","author":"Ernest","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1600-0897.1999.tb00087.x","article-title":"Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome","volume":"41","author":"Kutteh","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0165","series-title":"Recurrent pregnancy loss","author":"Schust","year":"2002"},{"key":"10.1016\/j.autrev.2014.05.004_bb0170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/0961203310361490","article-title":"Obstetric antiphospholipid syndrome: current uncertainties should guide our way","volume":"19","author":"Branch","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0175","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/oxfordjournals.humrep.a136224","article-title":"Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0180","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.004_bb0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.004_bb0190","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.004_bb0195","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.revmed.2012.01.003","article-title":"Pregnancy and antiphospholipid syndrome","volume":"33","author":"Costedoat-Chalumeau","year":"2012","journal-title":"Revue de Medecine Interne"},{"key":"10.1016\/j.autrev.2014.05.004_bb0200","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/AOG.0b013e3181fe02ec","article-title":"Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis","volume":"116","author":"do Prado","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12016-008-8100-3","article-title":"Pregnancy and catastrophic antiphospholipid syndrome","volume":"36","author":"Gomez-Puerta","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0210","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","article-title":"Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","volume":"142","author":"De Wolf","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-2243(91)90021-C","article-title":"Histopathological finding from patient with intrauterine fetal death and antiphospholipid antibodies","volume":"41","author":"Out","year":"1991","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0225","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","article-title":"Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure","volume":"17","author":"Sebire","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203309361351","article-title":"Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view","volume":"19","author":"Meroni","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0897.2011.01048.x","article-title":"Endometrial receptivity and human embryo implantation","volume":"66","author":"Rashid","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-3-56","article-title":"Human trophoblast function during the implantation process","volume":"3","author":"Staun-Ram","year":"2005","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0245","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","article-title":"Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction","volume":"203","author":"Girardi","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0250","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10815-007-9152-7","article-title":"Angiogenesis in implantation","volume":"24","author":"Torry","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.autrev.2014.05.004_bb0255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","article-title":"Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I","volume":"43","author":"Di Simone","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.004_bb0260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2004.021444","article-title":"Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro","volume":"64","author":"Di Simone","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.004_bb0265","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0015-0282(01)03258-7","article-title":"Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules","volume":"77","author":"Di Simone","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2014.05.004_bb0270","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis","volume":"83","author":"Di Simone","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2010.06.013","article-title":"In vivo modulation of angiogenesis by beta 2 glycoprotein I","volume":"35","author":"Passam","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.004_bb0280","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood-2008-12-190629","article-title":"Nicked \u03b22-glycoprotein binds angiostatin 4.5 (plasminogen kringle 1\u20135) and attenuates its antiangiogenic property","volume":"114","author":"Nakagawa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0285","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2014.05.004_bb0290","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.autrev.2013.08.004","article-title":"The antiphospholipid syndrome and Tregs","volume":"13","author":"Staub","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0295","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12016-009-8183-5","article-title":"Complement activation and pregnancy failure","volume":"39","author":"Tincani","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0305","doi-asserted-by":"crossref","first-page":"J209","DOI":"10.1016\/j.jaut.2011.11.009","article-title":"Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the \u03b22 glycoprotein I phospholipid-binding site. Implications for human fetal loss","volume":"38","author":"de la Torre","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.004_bb0310","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2012.04.001","article-title":"Anti-phosphatidylserine, anti-cardiolipin, anti-\u03b22 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8\u201312gestationalweeks","volume":"163","author":"Sater","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.autrev.2012.07.008","article-title":"Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome","volume":"12","author":"Staub","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0320","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jri.2010.12.009","article-title":"Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recurrent spontaneous miscarriage","volume":"89","author":"Sater","year":"2011","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2011.04.011","article-title":"New autoantigens in the antiphospholipid syndrome","volume":"10","author":"Alessandri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1186\/ar4549","article-title":"Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers","author":"Meroni","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.05.004_bb0335","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"Yetman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2014.05.004_bb0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0897.2001.d01-19.x","article-title":"Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients","volume":"46","author":"Matsubayashi","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0345","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1447-0756.2004.00206.x","article-title":"Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss","volume":"30","author":"Sugi","year":"2004","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.autrev.2014.05.004_bb0350","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1196\/annals.1422.048","article-title":"Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization","volume":"1108","author":"Sanmarco","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.05.004_bb0355","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jri.2008.11.001","article-title":"Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes","volume":"79","author":"Yamada","year":"2009","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0360","series-title":"The autoantibodies","first-page":"741","article-title":"Phospholipid autoantibodies (non-anticardiolipin)\u2013anti-prothrombin antibodies","author":"Pregnolato","year":"2014"},{"key":"10.1016\/j.autrev.2014.05.004_bb0365","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0370","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0897.2006.00434.x","article-title":"Autoantibodies and prediction of reproductive failure","volume":"56","author":"Shoenfeld","year":"2006","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0375","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1182\/blood.V88.11.4173.bloodjournal88114173","article-title":"Mechanisms and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid","volume":"88","author":"Rao","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1034\/j.1600-0897.2003.01153.x","article-title":"Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome","volume":"49","author":"von Landerberg","year":"2003","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0385","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1373\/clinchem.2006.073098","article-title":"Increased plasma concentrations of anti-prothrombin antibodies in women with recurrent spontaneous abortions","volume":"53","author":"Sabatini","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2014.05.004_bb0390","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejogrb.2012.04.001","article-title":"Anti-phosphatidylserine, anti-cardiolipin, anti-beta 2 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8\u201312gestationalweeks","volume":"163","author":"Sater","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0395","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0897.2011.01031.x","article-title":"Antipropthrombin antibodies are associated with adverse pregnancy outcome","volume":"66","author":"Marozio","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0400","first-page":"28","article-title":"Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent early foetal loss","volume":"84","author":"Gris","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2014.05.004_bb0405","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0015-0282(01)02009-X","article-title":"Antiannexin V antibodies in patients with early pregnancy loss of implantation failure","volume":"26","author":"Matsubayashi","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2014.05.004_bb0410","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jri.2010.12.009","article-title":"Anti-annexin V IgM and IgG autoantibodies and the risk of idiopathic recurrent spontaneous miscarriage","volume":"89","author":"Sater","year":"2011","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0415","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1196\/annals.1313.037","article-title":"A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for foetal loss","volume":"1050","author":"Bizzaro","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.05.004_bb0420","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.medcli.2009.09.040","article-title":"Anti-annexin A5 antibodies in women with spontaneous pregnancy loss","volume":"134","author":"Alijotas-Reig","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.autrev.2014.05.004_bb0425","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0430","doi-asserted-by":"crossref","first-page":"485e17","DOI":"10.1016\/j.ajog.2011.06.019","article-title":"Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome","volume":"205","author":"Hunt","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0435","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ajog.2005.05.034","article-title":"Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses","volume":"194","author":"Rand","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12016-007-0010-2","article-title":"Anti-phospholipid antibodies and infertility","volume":"32","author":"Carp","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0445","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.fertnstert.2009.08.062","article-title":"Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure","volume":"93","author":"Sauer","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2014.05.004_bb0450","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/humrep\/14.10.2556","article-title":"Murine embryos as a direct target for some human autoantibodies","volume":"14","author":"Kaider","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0455","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0897.1998.tb00349.x","article-title":"High levels of anticardiolipin antibodies in patients with abnormal embryo morphology who attended an in vitro fertilization program","volume":"39","author":"Azem","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0460","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/oxfordjournals.humrep.a019125","article-title":"Defective maternal\u2013fetal interaction in a murine autoimmune model","volume":"11","author":"Tartakowsky","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0465","first-page":"777","article-title":"Angiogenesis and reproduction","volume":"108","author":"Smith","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.autrev.2014.05.004_bb0470","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0015-0282(99)00498-7","article-title":"Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis","volume":"73","author":"Hornstein","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.autrev.2014.05.004_bb0475","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1196\/annals.1422.048","article-title":"Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization","volume":"1108","author":"Sanmarco","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.05.004_bb0480","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome","volume":"13","author":"de Jesus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","article-title":"European registry of babies born to mothers with antiphospholipid syndrome","volume":"72","author":"Mekinian","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.004_bb0490","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/JPM.1999.025","article-title":"Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome","volume":"27","author":"Brewster","year":"1999","journal-title":"J Perinat Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0495","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.23311","article-title":"Neuropsychological development of children born to patients with antiphospholipid syndrome","volume":"59","author":"Nacinovich","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.004_bb0500","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2012.05.006","article-title":"Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome","volume":"12","author":"Mahler","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0505","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1542\/peds.2010-2846","article-title":"Prevalence of autism spectrum disorder in adolescents born weighing <2000grams","volume":"128","author":"Pinto-Martin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2014.05.004_bb0510","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1196\/annals.1361.088","article-title":"Hughes syndrome, the antiphospholipid syndrome: a new chapter in neurology","volume":"1051","author":"Sanna","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.05.004_bb0515","doi-asserted-by":"crossref","first-page":"579e1","DOI":"10.1016\/j.genhosppsych.2012.02.005","article-title":"Early neuropsychiatric involvement in antiphospholipid syndrome","volume":"34","author":"Lai","year":"2012","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.autrev.2014.05.004_bb0520","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1191\/0961203303lu500oa","article-title":"CNS dysfunction in the antiphospholipid syndrome","volume":"12","author":"Katzav","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0525","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1191\/0961203303lu392oa","article-title":"Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies","volume":"12","author":"Chapman","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0530","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/0961203310397564","article-title":"Pathological gambling and primary antiphospholipid (Hughes) syndrome: a unique neuropsychiatric association","volume":"20","author":"Barros","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0535","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11926-010-0148-4","article-title":"Update on antiphospholipid syndrome in children","volume":"13","author":"Myones","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2014.05.004_bb0540","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0545","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203310395054","article-title":"Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010","volume":"20","author":"Branch","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0550","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328344c3f7","article-title":"Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome)","volume":"23","author":"Hoppe","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0555","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2014.05.004_bb0560","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/14.2.489","article-title":"Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome","volume":"14","author":"Di Simone","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.autrev.2014.05.004_bb0565","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1074\/jbc.M110176200","article-title":"Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome","volume":"277","author":"Guerin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2014.05.004_bb0570","doi-asserted-by":"crossref","first-page":"e29660","DOI":"10.1371\/journal.pone.0029660","article-title":"Effect of Low molecular weight heparins (LMWHs) on antiphospholipid antibodies (aPL) \u2014 mediated inhibition of endometrial angiogenesis","volume":"7","author":"D'Ippolito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.05.004_bb0575","first-page":"1256-1252","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0580","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0585","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","article-title":"Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody","volume":"160","author":"Lockshin","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0590","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/0002-9378(93)90410-K","article-title":"Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients","volume":"169","author":"Silver","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0595","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0600","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.05.004_bb0605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2008.11.010","article-title":"Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome","volume":"104","author":"Dendrinos","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.autrev.2014.05.004_bb0610","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1385\/CRIAI:29:3:327","article-title":"Intravenous immunoglobulin and recurrent pregnancy loss","volume":"29","author":"Carp","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0615","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.autrev.2014.01.053","article-title":"14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends","volume":"13","author":"Erkan","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0620","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","article-title":"A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice","volume":"15","author":"Ostertag","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.004_bb0625","doi-asserted-by":"crossref","first-page":"J209","DOI":"10.1016\/j.jaut.2011.11.009","article-title":"Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the \u03b22 glycoprotein I phospholipid-binding site. Implications for human fetal loss","volume":"38","author":"de la Torre","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.05.004_bb0630","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/aji.12130","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis: protective effect of a synthetic peptide (TIFI) mimicking the phospholipid binding site of \u03b22 glycoprotein I","volume":"70","author":"Di Simone","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0635","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clim.2004.02.014","article-title":"Beta-2 glycoprotein I and its role in antiphospholipid syndrome-lessons from knockout mice","volume":"112","author":"Miyakis","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2014.05.004_bb0640","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","article-title":"Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies","volume":"12","author":"Comarmond","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2014.05.004_bb0645","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.004_bb0650","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-11-537704","article-title":"A non complement-fixing antibody to \u03b22 glycoprotein I as a novel therapy to control abortions and thrombosis in antiphospholipid syndrome","author":"Agostinis","year":"2014","journal-title":"Blood"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T07:56:52Z","timestamp":1597823812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":130,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1568997214001232"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}